3 hours Royal Bank of Canada Reaffirms “Outperform” Rating for Evolent Health (NYSE:EVH) MarketBeat
Royal Bank of Canada restated an “outperform” rating and set a $42.00 price target on shares of Evolent Health in a report on Tuesday.
Canada · Health · NYSE · Royal Bank of Canada